AMA weighs in on FDA’s regulatory proposal for GenAI-based medtech

The American Medical Association submitted comments on the FDA's proposed regulatory framework for generative AI-based medical devices, urging the agency to prioritize safety over speed in approval processes and calling for physician input on clinical performance standards and evaluation criteria for AI-driven medtech.